CONMED Corporation's (NYSE:CNMD) stock was strong after they recently reported robust earnings. However, our analysis suggests that shareholders may be missing some factors that indicate the earnings ...

Ratings for Conmed (NYSE:CNMD) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing ...

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in CONMED Corporation's (NYSE:CNMD) case, it's fantastic news for shareholders.

In the preceding three months, 6 analysts have released ratings for Conmed (NYSE:CNMD), presenting a wide array of perspectives from bullish to bearish. The table below provides a snapshot of their ...

Shares of medical tech company CONMED (NYSE:CNMD) jumped 3.3% in the afternoon session after positive sentiment in the medical device sector was buoyed by the highly successful initial public offering ...

CONMED’s Q2 2025 results demonstrated a notable improvement over its first quarter, when the company missed analyst expectations with an EPS of $0.79 against forecasts of $1.00. The second quarter’s ...

Conmed's ambitious revenue growth targets and ongoing operational issues have led to underperformance, with shares down 10% since my last update and ongoing concerns about growth, margins, and tariffs ...